World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02863835
Date of registration: 04/05/2016
Prospective Registration: No
Primary sponsor: Guy's and St Thomas' NHS Foundation Trust
Public title: Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients CLAD
Scientific title: Evaluation of Electrical Impedance Tomography for the Diagnosis of Chronic Rejection in Lung Transplants Recipients
Date of first enrolment: April 2016
Target sample size: 50
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02863835
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
United Kingdom
Contacts
Name:     Nick Hart
Address: 
Telephone:
Email:
Affiliation:  Guys and St Thomas' NHS Foundation Trust
Key inclusion & exclusion criteria

Inclusion Criteria:

- Bilateral lung transplant recipient

- Time from lung transplantation > 6 months

- A chest CT scan (HRCT) performed as part of their standard care in the last 3 months

- A bronchoscopy with BAL and Biopsies performed as part of their standard care in the
last 3 months

- For group with CLAD: a drop in lung function assessed on FEV1 or FVC

- For group without CLAD: an unchanged lung function

Exclusion Criteria:

- Pregnancy

- Body mass index > 40kg/m2

- Significant physical or psychiatric comorbidity that would prevent compliance with
trial protocol

- Allergy to salbutamol

- Patient with intra-bronchial or intra-tracheal metallic stent

- Evidence of acute infection or acute cellular rejection.

In addition 10 healthy volunteers will be recruited



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Bronchiolitis Obliterans Syndrome
Transplantation, Heart-Lung
Chronic Lung Allograft Dysfunction
Intervention(s)
Other: EIT
Other: Salbutamol nebulisation and with CPAP
Primary Outcome(s)
Number of chronic lung allograft dysfunction in lung transplant recipients identified with EIT [Time Frame: 1 day]
Restrictive and obstructive phenotypes in recipients of lung transplants. [Time Frame: 1 day]
Secondary Outcome(s)
Change in EIT results following administration of salbutamol and CPAP [Time Frame: 1 day]
Correlation between EIT and neural respiratory drive results with breathlessness [Time Frame: 1 day]
Correlation EIT results and chest-CT results [Time Frame: 1 day]
Neural respiratory drive (EMGpara) of lung transplant recipients [Time Frame: 1 day]
Correlation of EIT results found in obstructive and restrictive allograft syndrome [Time Frame: 1 day]
Secondary ID(s)
16/LO/0198
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
ADIR Association
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history